Scott Hensley, NPR, Dec. 22, 2021 In a highly anticipated decision, the Food and Drug Administration authorized the first antiviral pill to treat COVID-19 at home. The pill, called Paxlovid, is made by Pfizer. It’s taken twice a day for …
How vaccine-makers plan to address the new COVID-19 omicron variant
Dustin Jones, NPR, Nov. 28, 2021 A new strain of COVID-19 first discovered in South Africa was declared a variant of concern by the World Health Organization on Friday. Here’s how the pharmaceutical industry plans to address the latest coronavirus …
Welcoming family into your home for Thanksgiving? Here’s how to keep COVID out
Allison Aubrey, NPR, Nov. 20, 2021 Here’s one thing to be thankful for this year: It’s not Thanksgiving 2020. A year ago vaccines had not yet been approved, daily deaths were rising sharply – surging to more than 2,000 a …
All vaccinated adults could soon be eligible for a Pfizer COVID-19 booster shot
Jane GreenHalgh, NPR, Nov. 16, 2021 People 18 or older who are already considered fully vaccinated could soon be eligible to get a Pfizer-BioNTech COVID-19 vaccine booster shot. The Food and Drug Administration is expected to announce later this week …
CDC advisers recommend Pfizer’s COVID vaccine for children ages 5 through 11
Joe Neel and Carmel Wroth, NPR, Nov. 2, 2021 Children ages 5 through 11 years may soon be able to get a low-dose COVID-19 vaccine made by Pfizer-BioNTech. Advisors to the Centers for Disease Control and Prevention voted unanimously to …